50914-15-3

Usage

Uses

Used in Research and Development:
(2-iodophenyl)hydrazine is used as a precursor in the synthesis of various complex chemical compounds for [application reason] advancing scientific knowledge and developing new materials or pharmaceuticals. Its unique structure and reactivity make it a valuable component in creating novel molecules with specific properties.
Used in Chemical Synthesis Industry:
(2-iodophenyl)hydrazine is used as a building block for the creation of new chemical entities for [application reason] its potential to form a variety of derivatives that can be tailored for specific applications, such as pharmaceuticals, agrochemicals, or materials science.
Used in Pharmaceutical Development:
(2-iodophenyl)hydrazine is used as a key intermediate in the development of pharmaceutical compounds for [application reason] its ability to be modified and incorporated into drug molecules that target specific biological pathways or receptors.
Note: The specific applications and reasons for using (2-iodophenyl)hydrazine would depend on the particular field of research or industry. The provided materials do not specify the exact applications, so the uses listed are general and based on the compound's properties and typical uses in related fields.

Upstream product

• 615-43-0 2-iodophenylamine 

Downstream Products

• 63014-15-3 (2-iodo-phenylhydrazono)-acetic acid 
• 100212-78-0 D-arabino-[2]hexosulose-bis-(2-iodo-phenylhydrazone) 
• 1205-15-8 2-Jod-phenylhydrazincarbonsaeure-ethylester 
• 215452-46-3 2'-(2-iodophenyl)acetohydrazide 
• 1205-16-9 2-Jod-benzolazocarbonsaeure-aethylester 
• 1011527-97-1 3-(2-fluorobenzyl)-1H-indazole 
• 1380573-88-5 3-methyl-1-(2-iodophenyl)-1H-pyrazol-5-amine 
• 1380573-51-2 4-(4-phenoxyphenyl)-3,6-dimethyl-1-(2-iodophenyl)-4,8-dihydro-1H-pyrazolo[3,4-e][1,4]thiazepin-7-one 
• 1419605-60-9 1-(2-iodophenyl)-1H-pyrazole 
• 1419605-74-5 N-[2-(3,5-dimethylpyrazol-1-yl)phenyl]-N-benzylimidazolium tetrafluoroborate 
• 1419605-73-4 N-[2-(3,5-dimethylpyrazol-1-yl)phenyl]-N-benzylimidazolium hexafluorophosphate 
• 1419605-69-8 N-[2-(3,5-dimethylpyrazol-1-yl)phenyl]-N'-benzylimidazolium chloride 
• 1419605-67-6 N-[2-(pyrazol-1-yl)phenyl]-N'-benzylimidazolium chloride 

Relevant academic research and scientific papers

HALOALLYLAMINE SULFONE DERIVATIVE INHIBITORS OF LYSYL OXIDASES AND USES THEREOF

The present invention relates to novel compounds which are capable of inhibiting certain amine oxidase enzymes. These compounds are useful for treatment of a variety of indications, e.g., fibrosis, cancer and/or angiogenesis in human subjects as well as i

NITROGEN-CONTAINING FUSED RING COMPOUNDS FOR USE AS CRTH2 ANTAGONISTS

The present application relates to nitrogen-containing fused ring compounds shown by general formula (I), a pharmaceutically acceptable salt thereof and a stereoisomer thereof as CRTH2 antagonist, wherein X1, X2, X3, X4, X5, W, X, Y, L1, L2, L3, A, B are as defined in the description; the present application further relates to a method for preparing the compounds, a pharmaceutical formulation and a pharmaceutical composition comprising the compounds, a use of the compounds for the manufacture of a medicament for the treatment and/or prevention of diseases related to activity of CRTH2.

NITROGEN-CONTAINING FUSED RING COMPOUNDS AS CRTH2 ANTAGONISTS

The present application relates to nitrogen-containing fused ring compounds shown by general formula (I), a pharmaceutically acceptable salt thereof and a stereoisomer thereof as CRTH2 antagonist, wherein X1, X2, X3, X4, X5, W, X, Y, L1, L2, L3, A, B are as defined in the description; the present application further relates to a method for preparing the compounds, a pharmaceutical formulation and a pharmaceutical composition comprising the compounds, a use of the compounds for the manufacture of a medicament for the treatment and/or prevention of diseases related to activity of CRTH2.